Sanara MedTech Inc. develops, markets and distributes skin and wound care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company is headquartered in Fort Worth, Texas.
| Revenue (TTM) | $103.12M |
| Gross Profit (TTM) | $95.60M |
| EBITDA | $11.81M |
| Operating Margin | 10.50% |
| Return on Equity | -1.75% |
| Return on Assets | 7.10% |
| Revenue/Share (TTM) | $11.96 |
| Book Value | $0.66 |
| Price-to-Book | 26.40 |
| Price-to-Sales (TTM) | 1.51 |
| EV/Revenue | 1.827 |
| EV/EBITDA | 18.27 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4.70% |
| Shares Outstanding | $9.17M |
| Float | $3.85M |
| % Insiders | 64.05% |
| % Institutions | 21.35% |
Volatility is currently expanding